Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suglat vs Januvia in uncontrolled type 2 diabetes
NCT03076112Phase 3Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Apr 2017
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ipragliflozin in type 2 diabetes mellitus (T2DM), sponsored by Seoul National University Bundang Hospital. Started Apr 2017; status: completed.
02
Drugs
ipragliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03076112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03076112.